Scientific News

Why microbiome therapies are the next frontier in oncology

Elran Haber, CEO at Biomica Ltd, discussed the emerging role of microbiome-based treatments in cancer care.

Some gut microbes may boost a child’s brain development

By examining the gut-brain-microbiota axis in typical neurodevelopment, the findings could pave the way for identifying biomarkers for cognition and brain development.

A diverse gut microbiota prevents infection by blocking nutrient access

The findings of a recent study shed light on why gut microbiota diversity protects against infection. The results may also inform the design of pathogen-resistant microbial communities.

Immune signaling can influence tumors growth through microbial regulation

The findings of a recent study suggest that the crosstalk between gut microbes and the host’s immune system can influence the body’s defenses during cancer therapy.

Gut microbe eases social difficulties associated with autism, small clinical trial shows

The findings of a recent study suggest that L. reuteri eases social difficulties in autistic children.

Freya Biosciences: pioneering the development of microbial immunotherapies for women’s health

Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.

Gut microbes may promote the recovery of liver function in cancer patients

The findings of a recent study suggest that modulating the gut microbiota in people with liver cancer can improve their health outcomes after surgery.

How vaginal microbes are linked to pregnancy complications

The findings of a recent study suggest that in bacterial vaginosis, certain vaginal microbes disrupt the protective glycans on vaginal epithelial cells, altering processes that mediate cell turnover, death and…

Innovative Frontiers: AI-Driven Approaches to Microbiological Analysis

An open discussion about the future of microbiological analysis through AI integration with Franco Pirovano (Micro srl) and Federico Pirovano (Dynius).

Engineering Live biotherapeutics to treat complex respiratory diseases

Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, discusses the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex…

Study reveals the trajectory of phages in the infant gut ecosystem

The findings of a recent study suggest that different factors, including maternal seeding and phage persistence in the gut, contribute to the colonization of the gut by phages.

Gut microbes influence cognitive performance in baby mice

The findings of a recent study show that specific gut microbes and their metabolites affect cognition and memory when transplanted into germ-free mice.

The role of gut microbiota and mycobiota in pre-eclampsia

Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.

The cloudy link between gut microbes and obesity

Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.

Study characterizes the microbiota of milk from mothers with preterm infants

The findings of a recent study shed light on the microbiota of the main nutrition types that preterm infants receive and may inform future studies on the influence of different…

IBS DAYS 2024 in Bologna with experts from all over the world 

Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.

How gut bacteria can help relieve constipation

A recent study indicates that the abfA cluster might be used as therapeutic target for constipation in humans.

In Crohn’s disease model, a fiber-free diet inhibits colitis by regulating gut bacteria

The findings of a recent study may inform new approaches to treat Crohn’s disease by targeting disease-causing microbes in the gut.

Gut fungi may be linked to inflammation in severe COVID

The findings of a recent study suggest that mycobiota changes during a SARS-CoV-2 infection could contribute to inflammation associated with severe COVID.

‘Hidden’ bacteria could explain recurrent urinary tract infections

The findings of a recent study indicate that effective treatments for recurrent UTIs may require the ability to penetrate human tissues.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top